Cyrus Biotechnology Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Employees
  • 24
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $10.2M
Latest Deal Amount
  • Investors
  • 14

Cyrus Biotechnology General Information

Description

Developer of a protein structure prediction and design software designed to learn the use of tools for molecular modeling. The company's software provides a portal for protein structure prediction, modeling, stabilization, engineering and design to accelerate the discovery of biology and small molecules, enabling users to get assistance in molecular, homology and protein modeling.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Enterprise Systems (Healthcare)
Primary Office
  • 1201 Second Avenue
  • Suite 900
  • Seattle, WA 98101
  • United States
+1 (206) 000-0000

Cyrus Biotechnology Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyrus Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 06-Jul-2021 $10.2M 000.00 Completed Generating Revenue
5. Debt - PPP 15-Apr-2020 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 27-Jul-2017 00.000 000.00 0000 Completed Generating Revenue
3. Seed Round 17-Feb-2017 00.000 00.000 00.000 Completed Generating Revenue
2. Grant 01-Jan-2016 $225K Completed Generating Revenue
1. Grant 12-Dec-2014 $50K Completed Startup
To view Cyrus Biotechnology’s complete valuation and funding history, request access »

Cyrus Biotechnology Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00 00.00 00.00 00 00.00 000
Seed 0,000,000 00.000000 00 00.0 00.0 00 00.0 00.000
To view Cyrus Biotechnology’s complete cap table history, request access »

Cyrus Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of a protein structure prediction and design software designed to learn the use of tools for molecular modelin
Other Healthcare Technology Systems
Seattle, WA
24 As of 2021
000.00
0000000000 0 000.00

0000000

dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliq
00000 0000000000 0000000000 0000000
Litlington, United Kingdom
00 As of 0000
0000000000

00000000

olore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqu
0000000 0000000000 (0000000000)
Montreal, Canada
00 As of 0000
00000000. 00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Cyrus Biotechnology Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Cresset (england) Corporation Litlington, United Kingdom 00 0000000000
00000000 000000000 Private Equity-Backed Montreal, Canada 00 00000000. 00
0000000 0000000000 Corporation Santa Fe, NM
0000000000 Venture Capital-Backed Oxford, United Kingdom 000 00000 0000000000 0 00000
To view Cyrus Biotechnology’s complete competitors history, request access »

Cyrus Biotechnology Executive Team (5)

Name Title Board Seat Contact Info
Lucas Nivon Ph.D Chief Executive Officer, Board Member and Co-Founder
Yifan Song Ph.D Chief Science Officer, Board Member and Co-Founder
Rosario Caltabiano Executive Vice President, Sales
David Baker Scientific Co-Founder & Advisor
You’re viewing 4 of 5 executive team members. Get the full list »

Cyrus Biotechnology Board Members (7)

Name Representing Role Since
Augustus Tai Trinity Ventures Board Member 000 0000
Carl Gordon Ph.D OrbiMed Board Observer 000 0000
Chad Waite Jr. The W Fund Board Member 000 0000
Eric Bell SpringRock Ventures Board Member 000 0000
Eric Larsen Self Board Observer 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Cyrus Biotechnology Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyrus Biotechnology Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
OrbiMed PE/Buyout Minority 000 0000 000000 0
Sahsen Ventures Venture Capital Minority 000 0000 000000 0
SpringRock Ventures Venture Capital Minority 000 0000 000000 0
Trinity Ventures Venture Capital Minority 000 0000 000000 0
Alok Chanani Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »